Reverse vaccinology is a powerful tool that was recently used to develop vaccines starting
from a pathogen genome. Some bacterial infections have the necessity to be prevented then …

Introduction Nontuberculous mycobacteria (NTM) infections have emerged as a significant
clinical challenge due to their intrinsic multidrug resistance and the limited efficacy of …

Patients with cystic fibrosis (CF) are prone to developing life-threatening lung infections with
a variety of pathogens that are difficult to eradicate, such as Burkholderia cepacia complex …

In the 19 th century, the discovery of penicillin revolutionized medicine, saving millions from
infectious diseases. People believed that they had won the war against infections. However …

Mycobacterium abscessus has recently emerged as the cause of an increasing number of
human infections worldwide. Unfortunately, it is highly resistant to existing drugs, and new …

Mycobacterium abscessus is an emerging opportunistic pathogen that infects mainly the
respiratory tract of individuals with pre-existing clinical pictures. In recent years, the …

Background Mycobacterium abscessus, a fast-growing non-tuberculous mycobacterium, is
an emerging opportunistic pathogen responsible for chronic bronchopulmonary infections in …

Blocking iron uptake and metabolism has been emerging as a promising therapeutic
strategy for the development of novel antimicrobial compounds. Like all mycobacteria, M …

Given the current need for predictive persisting model for Mycobacterium abscessus, we
adopted a classical assay to study drug-tolerant bacterial persisters, focusing on the …

Mycobacterial infections caused by tuberculous and non-tuberculous strains pose significant
treatment challenges, especially among immunocompromised patients. Conventional …